Aragen’s goal was to see if their production process could be easily scaled up to larger, single-use bioreactors. Learn more about their findings.

Facing the dual challenge of boosting efficiency and reducing strain of staff, a leading sterilization provider in Japan has digitalized their sterile reprocessing.

Explore the future of pharmaceutical manufacturing with 4 key trends in sterile component transfer. From pre-validated solutions to manufacturing flexibility and increased automation, discover how industry leaders Getinge and West are shaping the landscape.

Discover how our DPTE® rapid transfer port, tested in collaboration with SafeBridge® Regulatory & Life Sciences Group, ensures personnel and environmental safety in pharmaceutical manufacturing facilities. Read the assessment of containment performance, validating the effectiveness of the DPTE® Alpha port against potentially hazardous active pharmaceutical ingredients.

The pharmaceutical industry constantly seeks innovations that enhance the safety, efficiency, and precision of drug production. One such revolutionary technology that has significantly impacted the industry is the DPTE® system, introduced in the 1960s. This article explores the history and evolution of DPTE®, highlighting its pivotal role in pharmaceutical production and the extensive experience that Getinge brings to the table after 60 years in the field.

A new pre-validated wash rack, enabling the staff at Fujirebio to create a standardized cleaning process of multi-use bioreactors which saves time in their important work to produce more antibodies used in cancer diagnostics.

Ensure guidance of your unexperienced staff and adapt to different user competency levels while maintaining a high and consistent quality level of the sterile production.